Efficacy of Ibrutinib-Based Regimen in Chronic Lymphocytic Leukemia: A Systematic Review

Ibrutinib has shown to have better efficacy than standard chemoimmunotherapy in del17 positive chronic lymphocytic leukemia (CLL) patients; however its role in del17 negative patients is less clear. We aim to evaluate the efficacy of ibrutinib-based regimens in CLL. Seven databases were searched in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sardar, Muhammad, Malik, Saad ullah, Khan, Ali, Idrees, Muhammad, Ahmad, Qistas, Sohail, Chaudhry, Naseer, Raza, Amin, Saher, McBride, Ali, Abuzar, Muhammad, Safdar, Ahmed, Chakraborty, Rajshekhar, Lee, Patrick, Sharon, David, Anwer, Faiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153674/
https://www.ncbi.nlm.nih.gov/pubmed/32300434
http://dx.doi.org/10.14740/jh482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153674/
https://www.ncbi.nlm.nih.gov/pubmed/32300434
http://dx.doi.org/10.14740/jh482

Ejemplares similares